Nuvo Pharmaceuticals Inc. announced the appointment of Jesse Ledger as its President & Chief Executive Officer. Mr. Ledger was previously President of the Company. Mr. Ledger assumes the CEO role from John London who will become the Company's Executive Chairman and continue to serve on its board of directors.

Dan Chicoine, previously Chairman of the Company, will continue as a member of the board. The appointment of Mr. Ledger is the final step in a CEO succession plan adopted by the Nuvo board of directors in 2016. Ledger has over 15 years of pharmaceutical experience with a proven expertise in business development.

Prior to joining Nuvo in April of 2015, he was Vice President of Business Development and International Business at Tribute Pharmaceuticals Canada.